Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 76

Sort by

Sort Order Select

Journal Articles

A Retrospective Analysis of Orelabrutinib-Containing Regimen for Marginal Zone Lymphoma

Hua Wang, Yang Liang, Dong Liang, Demei Feng

Blood (2024) 144 (Supplement 1): 6332.

https://doi.org/10.1182/blood-2024-203319

Published: 2024

Journal Articles

Elucidation of Molecular Mechanisms of Iberdomide and Mezigdomide Resistance in Cell Line Models of Multiple Myeloma

Wei Tan, Minghao Dang, Upasana Ray, Luz Yurany Moreno Rueda, Maria Jose Acevedo-Calado, Hua Wang, Jun Wei, Li Qin, Isere Kuiatse, Robert Z. Orlowski

Blood (2024) 144 (Supplement 1): 4640.

https://doi.org/10.1182/blood-2024-207917

Published: 2024

Journal Articles

Treatment Outcomes of Zanubrutinib-Based Regimen in Newly Diagnosed Patients with MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Real-World Study

Bo Lu, Jihao Zhou, Fangjie Liu, Jingwei Zhang, Hua Wang

Blood (2024) 144 (Supplement 1): 6517.

https://doi.org/10.1182/blood-2024-200733

Published: 2024

Journal Articles

Safety and Efficacy of Selinexor Plus Bortezomib, Lenalidomide and Dexamethasone (XVRd) in High Risk Newly Diagnosed Multiple Myeloma: A Multi-Center, Single-Arm, Phase Ib/II Trial

Xiaoqin Chen, Yun Wang, Weida Wang, Hua Wang, Bingyi Wu, Yang Liang, Zhongjun Xia

Blood (2024) 144 (Supplement 1): 7025.

https://doi.org/10.1182/blood-2024-204564

Published: 2024

Journal Articles

Sustained FVIII Expression with a Tolerable, Titratable, Fully Non-Viral Gene Therapy for Hemophilia a

Johannes Schwerk, Mauricio Barajas-Mora, Hua Wang, Brian Truong, Michael Bennett, Nicholas Cam, James Clancey, Alicia Davis, Khal Hajj, Bonnie Jacques, Johnnatan Tamayo, James Yen, Joshua Rychak, Blair Madison

Blood (2024) 144 (Supplement 1): 7462.

https://doi.org/10.1182/blood-2024-211223

Published: 2024

Journal Articles

Carfilzomib, Pomalidomide, Dexamethasone with and without Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multi-Center, Prospective Real World Study in China

Fujing Zhang, Wei Wang, Hua Wang, Wei Wang, Aijun Liu, Weiwei Tian, Xiaoqi Qin, Zhongjun Xia, Junling Zhuang

Blood (2024) 144 (Supplement 1): 6985.

https://doi.org/10.1182/blood-2024-209342

Published: 2024

Journal Articles

Efficacy and Safety of Carfilzomib-Based Regimens in a Real-World Clinical Practice: Insights from China

Dong Liang, Demei Feng, Yang Liang, Hua Wang

Blood (2024) 144 (Supplement 1): 7875.

https://doi.org/10.1182/blood-2024-203304

Published: 2024

Journal Articles

Mitoxantrone Hydrochloride Liposome Combined with Cytarabine As Induction Therapy for Patients with Newly Diagnosed Secondary Acute Myeloid Leukemia

Yun Wang, Weida Wang, Jingbo Xu, Ji Ma, Hua Wang, Bingyi Wu, Yuanbin Song, Weiran Lv, Lezong Chen, Jun Ma, Tiejun Gong, Yang Liang

Blood (2024) 144 (Supplement 1): 6074.

https://doi.org/10.1182/blood-2024-209055

Published: 2024

Journal Articles

Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High-Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients with Newly Diagnosed Multiple Myeloma (NDMM): Insights from a Multi-Center Study

Dong Liang, Demei Feng, Qiaoli Wang, Shenrui Bai, Min Zeng, Bo Lu, Xiaoqing Li, Zhiqiang Sun, Jianyun Li, Huanhuan Zhou, Jialu Zhang, Xiaoqin Chen, Zhongjun Xia, Yang Liang, Hua Wang

Blood (2024) 144 (Supplement 1): 7064.

https://doi.org/10.1182/blood-2024-204519

Published: 2024

Journal Articles

Fatty Acid Metabolism Shapes Immune Function and PI3K Inhibitor Sensitivity in Chronic Lymphocytic Leukemia

Yang Zhang, Jun Ma, Hua Wang, Pan Gao, Xin Wang, Ya Zhang

Blood (2024) 144 (Supplement 1): 6763.

https://doi.org/10.1182/blood-2024-208098

Published: 2024

Journal Articles

A Survival Prognostic Model for Gastro-Intestinal Non-Hodgkin Lymphoma

Shaojie Wu, Junru Du, Jie Ma, Li Huang, Zhiqiang Peng, Yiwen Ling, Xiaofang Deng, Weijian Zhu, Hongliang Li, Hua Wang, Yuhua Li

Blood (2024) 144 (Supplement 1): 3087.

https://doi.org/10.1182/blood-2024-200667

Published: 2024

Journal Articles

PRMT1 Promotes Chronic Lymphocytic Leukemia Progression Via Modulating Methylation of MAST1

Zheng Tian, Ya Zhang, Hua Wang, Liyan Lu, Xin Wang

Blood (2023) 142 (Supplement 1): 4628.

https://doi.org/10.1182/blood-2023-183058

Published: 2023

Journal Articles

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Blood (2023) 142 (Supplement 1): 2624.

https://doi.org/10.1182/blood-2023-174698

Published: 2023

Journal Articles

Lysosomal Associated Membrane Protein Family Member 5 (LAMP5) As a Novel Mediator of, and Target in High Risk Multiple Myeloma (MM)

Hua Wang, Luz Yurany Moreno Rueda, Minghao Dang, Luz Yurany Moreno Rueda, Hans C. Lee, Krina K. Patel, Sheeba K. Thomas, Donna M. Weber, Elisabet E. Manasanch, David E. Symer, Robert Z. Orlowski

Blood (2023) 142 (Supplement 1): 873.

https://doi.org/10.1182/blood-2023-189286

Published: 2023

Journal Articles

Causal Relationships between Immune-Mediated Inflammatory Diseases and Hodgkin's Lymphoma: A Mendelian Randomization Study

Junyun Yuan, Ya Zhang, Xinting Hu, Hua Wang, Zheng Tian, Liyan Lu, Xin Wang

Blood (2023) 142 (Supplement 1): 3065.

https://doi.org/10.1182/blood-2023-184534

Published: 2023

Journal Articles

Tumor Heterogeneity-Based Sscr-Score Predicts Prognosis and Reveals Mechanism of SORL1 in Restraining CLL Progression

Zheng Tian, Hua Wang, Xinting Hu, Yang Han, Xin Zhang, Tiange Lu, Mengfei Ding, Ya Zhang, Xin Wang

Blood (2022) 140 (Supplement 1): 12371–12372.

https://doi.org/10.1182/blood-2022-165608

Published: 2022

Journal Articles

Investigation of Lipid Metabolism Dysregulation in Chronic Lymphocytic Leukemia and the Role of ENPP2 in Tumorigenesis of Chronic Lymphocytic Leukemia

Liyan Lu, Ya Zhang, Xinting Hu, Yang Han, Xiaoya Yun, Hua Wang, Xin Zhang, Zheng Tian, Xin Wang

Blood (2022) 140 (Supplement 1): 12382–12383.

https://doi.org/10.1182/blood-2022-167985

Published: 2022

Journal Articles

APG115 Enhances the Sensitivity of Ibrutinib Via Promoting p53 to Target MCL-1 in Chronic Lymphocytic Leukemia

Yang Han, Ya Zhang, Xinting Hu, Hua Wang, Xin Zhang, Zheng Tian, Xin Wang

Blood (2022) 140 (Supplement 1): 5982–5983.

https://doi.org/10.1182/blood-2022-166774

Published: 2022

Journal Articles

BRD9 Facilitates Oncogenic Nrf2 Pathway and Dampens Venetoclax Sensitivity By Remodeling Chromatin Accessibility in Chronic Lymphocytic Leukemia

Xinting Hu, Ya Zhang, Hua Wang, Yang Han, Zheng Tian, Xin Zhang, Liyan Lu, Xin Wang

Blood (2022) 140 (Supplement 1): 356–357.

https://doi.org/10.1182/blood-2022-163284

Published: 2022

Journal Articles

BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation

Bing Li, Wenbin An, Hua Wang, Timour Baslan, Shoron Mowla, Aishwarya Krishnan, Wenbin Xiao, Richard P. Koche, Ying Liu, Sheng F. Cai, Zhijian Xiao, Andriy Derkach, Ilaria Iacobucci, Charles G. Mullighan, Kristian Helin, Scott W. Lowe, Ross L. Levine, Raajit K. Rampal

Blood (2022) 139 (25): 3630–3646.

https://doi.org/10.1182/blood.2021014465

Published: 2022

Includes: Supplemental data

NARROW

A Retrospective Analysis of Orelabrutinib-Containing Regimen for Marginal Zone Lymphoma

Elucidation of Molecular Mechanisms of Iberdomide and Mezigdomide Resistance in Cell Line Models of Multiple Myeloma

Treatment Outcomes of Zanubrutinib-Based Regimen in Newly Diagnosed Patients with MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Real-World Study

Safety and Efficacy of Selinexor Plus Bortezomib, Lenalidomide and Dexamethasone (XVRd) in High Risk Newly Diagnosed Multiple Myeloma: A Multi-Center, Single-Arm, Phase Ib/II Trial

Sustained FVIII Expression with a Tolerable, Titratable, Fully Non-Viral Gene Therapy for Hemophilia a

Carfilzomib, Pomalidomide, Dexamethasone with and without Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multi-Center, Prospective Real World Study in China

Efficacy and Safety of Carfilzomib-Based Regimens in a Real-World Clinical Practice: Insights from China

Mitoxantrone Hydrochloride Liposome Combined with Cytarabine As Induction Therapy for Patients with Newly Diagnosed Secondary Acute Myeloid Leukemia

Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High-Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients with Newly Diagnosed Multiple Myeloma (NDMM): Insights from a Multi-Center Study

Fatty Acid Metabolism Shapes Immune Function and PI3K Inhibitor Sensitivity in Chronic Lymphocytic Leukemia

A Survival Prognostic Model for Gastro-Intestinal Non-Hodgkin Lymphoma

PRMT1 Promotes Chronic Lymphocytic Leukemia Progression Via Modulating Methylation of MAST1

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Lysosomal Associated Membrane Protein Family Member 5 (LAMP5) As a Novel Mediator of, and Target in High Risk Multiple Myeloma (MM)

Causal Relationships between Immune-Mediated Inflammatory Diseases and Hodgkin's Lymphoma: A Mendelian Randomization Study

Tumor Heterogeneity-Based Sscr-Score Predicts Prognosis and Reveals Mechanism of SORL1 in Restraining CLL Progression

Investigation of Lipid Metabolism Dysregulation in Chronic Lymphocytic Leukemia and the Role of ENPP2 in Tumorigenesis of Chronic Lymphocytic Leukemia

APG115 Enhances the Sensitivity of Ibrutinib Via Promoting p53 to Target MCL-1 in Chronic Lymphocytic Leukemia

BRD9 Facilitates Oncogenic Nrf2 Pathway and Dampens Venetoclax Sensitivity By Remodeling Chromatin Accessibility in Chronic Lymphocytic Leukemia

BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only